VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-00403 Package ID: USCOURTS-cofc-1_20-vv-00403 Petitioner: Kelsie Reynolds Filed: 2021-02-02 Decided: 2021-03-05 Vaccine: influenza Vaccination date: 2017-09-26 Condition: Guillain-Barré syndrome (GBS) Outcome: compensated Award amount USD: 70000 AI-assisted case summary: Kelsie Reynolds filed a petition for compensation under the National Vaccine Injury Compensation Program on February 2, 2021, alleging she developed Guillain-Barré syndrome (GBS) as a result of an influenza vaccination received on September 26, 2017. Respondent denied that Petitioner sustained a Table injury within the specified time period, denied that the vaccine caused her injuries, and denied that she experienced residual effects for more than six months. Despite these denials, the parties filed a joint stipulation on February 2, 2021, agreeing that compensation should be awarded. Chief Special Master Corcoran found the stipulation reasonable and adopted it as the decision. The court awarded Kelsie Reynolds a lump sum of $70,000.00, representing compensation for all items of damages available under Section 15(a) of the Vaccine Act. This decision was entered on March 5, 2021. Theory of causation field: Table Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_20-vv-00403-0 Date issued/filed: 2021-03-05 Pages: 8 Docket text: PUBLIC DECISION (Originally filed: 02/02/2021) regarding 24 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 1 of 8 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-0403V UNPUBLISHED KELSIE REYNOLDS, Chief Special Master Corcoran Petitioner, Filed: February 2, 2021 v. Special Processing Unit (SPU); Joint SECRETARY OF HEALTH AND Stipulation on Damages; Influenza HUMAN SERVICES, (Flu) Vaccine; Guillain-Barre Syndrome (GBS) Respondent. Maximillian J. Muller, Muller Brazil, LLP, Dresher, PA, for petitioner. Emilie Williams, U.S. Department of Justice, Washington, DC, for respondent. DECISION ON JOINT STIPULATION1 On April 8, 2020, Kelsie Reynolds filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she developed Guillain-Barré syndrome (“GBS”) as a result of an influenza (“flu”) vaccination that she received on September 26, 2017. Petition at 1; Stipulation, filed on February 2, 2021, at ¶¶ 2, 4. Petitioner further alleges she received the vaccine in the United States, that she experienced the residual effects of her injury for more than six months, and that there has been no prior award or settlement of a civil action for damages as a result of her alleged condition. Petition at 1, 4; Stipulation at ¶¶ 2-5. “Respondent denies that [P]etitioner sustained the onset of a GBS Table injury within the time period set forth in the Table; denies that the vaccine caused or significantly aggravated [P]etitioner’s alleged injuries or any other injury or [P]etitioner’s current disabilities; and denies that [P]etitioner experienced the residual effects of this injury for more than six months. ” Stipulation at ¶ 6. 1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 2 of 8 Nevertheless, on February 2, 2021, the parties filed the attached joint stipulation, stating that a decision should be entered awarding compensation. I find the stipulation reasonable and adopt it as my decision awarding damages, on the terms set forth therein. Pursuant to the terms stated in the attached Stipulation, I award the following compensation: A lump sum of $$70,000.00 in the form of a check payable to Petitioner. Stipulation at ¶ 8. This amount represents compensation for all items of damages that would be available under Section 15(a). Id. I approve the requested amount for Petitioner’s compensation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 3 of 8 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 4 of 8 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 5 of 8 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 6 of 8 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 7 of 8 Case 1:20-vv-00403-UNJ Document 29 Filed 03/05/21 Page 8 of 8